When it comes to medical device companies and "corporate responsibility", they tend to the take the matter very serious due to ethical obligations and regulatory requirements. To start with regulatory accountability, medical device companies need to follow the stringent safety protocols that regulatory bodies like the FDA and EMA enforce on them. This includes continuous risk assessments and detailed quality assurance processes. Violating such protocols can have long-lasting effects to the company including fines and bans from certain markets, which severely impacts the reputation and finances of the company. Furthermore, medical device companies have to be even more adamant about "corporate responsibilities" due to patient safety and ethical obligations. Device failures or malfunctions can directly harm patients, and public backlash against negligence can be swift and lasting. Not only that, but ethical practices are also crucial to gaining the trust of healthcare providers and patients. In summary, medical device companies are generally very adamant about taking corporate responsibility because doing so is essential for regulatory compliance, ethical standards, patient safety, and the company’s own reputation and longevity.

I think that design controls "force" the company to be responsible for having a product that works and does not harm anyone. At the end of the day, biomedical device companies are businesses, so the main motivator is the monetary success of the company. As much as it is important to make a product from sales, it is just as important to save money. Any shortcut a company takes that is at the cost of safety or quality will come back to haunt the company. I do not think that all companies are innocent and would never take actions that might not be the most ethical. It certainly happens, maybe more than we know or think. However, one audit, one finding, can bring the whole operation crashing down. There are areas where non ethical actions can take place, such as in data manipulation, assigning "blame" on other entities, such as a supplier, instead of the design of the product, among other areas. However, there are some shortcuts that simply cannot happen, because of the safeguards set by the authoritative bodies. My confidence in companies on their faithfulness to design controls, quality, and safety cannot be a certain statement. Based on a company's performance, reputation, and their actions to correct issues in the field, one can make a reasonable assessment of how the company operates internally.

In the world of medical devices, I would imagine that companies take corporate responsibilities pretty seriously because patient safety and following FDA regulations are highly crucial. How companies actually commit however, depends on the company itself. Some factors are the company's culture, budget, and pressure to pump products out to the market. Larger medical device companies have solid processes for quality control because a lot of money was invested in research and testing. Design controls are there to make sure devices are safe and properly designed. That being said, even though most companies aim to release a solid product, some might cut corners under tight deadlines, leading to ethical gray areas. Smaller companies, especially startups, might feel this even more, trying to balance between being thorough and also saving as much money as they can.

Medical device manufacturing companies have more crucial and sensitive responsibilities than other corporate sectors. Medical devices have a direct impact on the health and wellness of society. Despite medical companies abiding by FDA or ISO standards, new or small companies choose shortcuts due to small budgets and lack of expert staff. Otherside established companies have already earned profit and credit from the market, so they are in a position to afford expenses to meet with expensive and tight regulation. According to me, to support new and small companies in maintaining regulatory standards, the government should provide them guidance from experts and relaxation in federal taxes. This will help them reduce overall costs and fulfill regulatory standards. Ultimately, society will remain assured of the quality of health and wellness.